Immuno-targeting the multifunctional CD38 using nanobody-Reference-Cited by-同舟云学术

Immuno-targeting the multifunctional CD38 using nanobody

Published:2016-06 Issue:1 Volume:6 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Li Ting,Qi Shali,Unger Mandy,Hou Yun Nan,Deng Qi Wen,Liu Jun,Lam Connie M. C.,Wang Xian Wang,Xin Du,Zhang Peng,Koch-Nolte Friedrich,Hao Quan,Zhang Hongmin,Lee Hon Cheung,Zhao Yong Juan

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep27055.pdf

Reference56 articles.

1. Lee, H. C. Cyclic ADP-ribose and nicotinic acid adenine dinucleotide phosphate (NAADP) as messengers for calcium mobilization. J Biol Chem 287, 31633–31640, doi: R112.349464/jbc.R112.349464 (2012).

2. Lee, H. C. Cyclic ADP-ribose and NAADP: fraternal twin messengers for calcium signaling. Sci China Life Sci 54, 699–711, doi: 10.1007/s11427-011-4197-3 (2011).

3. Zhao, Y. J., Lam, C. M. & Lee, H. C. The membrane-bound enzyme CD38 exists in two opposing orientations. Sci Signal 5, ra67, doi: 5/241/ra67 /scisignal.2002700 (2012).

4. Dianzani, U. et al. Modulation of CD4 lateral interaction with lymphocyte surface molecules induced by HIV-1 gp120. Eur J Immunol 25, 1306–1311, doi: 10.1002/eji.1830250526 (1995).

5. Savarino, A. et al. Human CD38 interferes with HIV-1 fusion through a sequence homologous to the V3 loop of the viral envelope glycoprotein gp120. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 17, 461–463, doi: 10.1096/fj.02-0512fje (2003).

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structural trends in antibody-antigen binding interfaces: a computational analysis of 1833 experimentally determined 3D structures;Computational and Structural Biotechnology Journal;2024-12

2. Nanobody‐based heavy chain antibodies and chimeric antibodies;Immunological Reviews;2024-08-30

3. Promising Diagnostic and Therapeutic Approaches Based on VHHs for Cancer Management;Cancers;2024-01-15

4. Bispecific Complement Engagers for Targeted Complement Activation;The Journal of Immunology;2023-06-23

5. Engineering Nanobody Targeting Cancer Stem Cells;Cancer Stem Cells: Basic Concept and Therapeutic Implications;2023